Outcomes of listing for lung and heart–lung transplantation in pulmonary hypertension: comparative experience in France and the UK

Author:

Pradère PaulineORCID,Le Pavec Jérome,Bos Saskia,Pozza Andre,Nair Arun,Meachery Gerard,Lordan James,Humbert MarcORCID,Mercier Olaf,Fadel Elie,Savale LaurentORCID,Fisher Andrew J.

Abstract

BackgroundLung or heart–lung transplantation (LT/HLT) for severe pulmonary hypertension (PH) as the primary disease indication carries a high risk of waiting list mortality and post-transplant complications. France and the UK both have coordinated PH patient services but with different referral pathways for accessing LT services.MethodsWe conducted a comparative analysis of adult PH patients listed for LT/HLT in the UK and France.ResultsWe included 211 PH patients in France (2006–2018) and 170 in the UK (2010–2019). Cumulative incidence of transplant, delisting and waiting list death within 3 years were 81%, 4% and 11% in Franceversus58%, 10% and 15% in the UK (p<0.001 for transplant and delisting; p=0.1 for death). Median non-priority waiting time was 45 days in Franceversus165 days in the UK (p<0.001). High-priority listing occurred in 54% and 51% of transplanted patients respectively in France and the UK (p=0.8). Factors associated with achieving transplantation related to recipients’ height, male sex, clinical severity and priority listing status. 1-year post-transplant survival was 78% in France and 72% in the UK (p= 0.04).ConclusionAccess to transplantation for PH patients is better in France than in the UK where more patients were delisted due to clinical deterioration because of longer waiting time. High rates of priority listing occurred in both countries. Survival for those achieving transplantation was slightly better in France. Ensuring optimal outcomes after transplant listing for PH patients is challenging and may involve early listing of higher risk patients, increasing donor lung utilisation and improving allocation rules for these specific patients.

Publisher

European Respiratory Society (ERS)

Reference35 articles.

1. NHS Blood and Transplant . Organ and Tissue Donation and Transplantation Activity Report 2020/21. Date last accessed: 15 October 2023. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/24053/activity-report-2020-2021.pdf

2. Agence de la Biomedecine . Organ retrieval for transplantation: General report. Date last accessed: 26 May 2023. https://rams.agence-biomedecine.fr/le-prelevement-dorganes-en-vue-de-greffe-0

3. Lung transplantation for pulmonary arterial hypertension;Kolaitis;Chest,2023

4. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

5. The evolution of survival of pulmonary arterial hypertension over 15 years;Hendriks;Pulm Circ,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3